Could a new imaging technique that is able to detect the distant spread of melanoma to the lymph nodes help patients avoid potentially risky surgery?
Men with prostate cancer who carry variants in the SLCO2B1 gene have shorter time to progression and overall survival.
On December 11, 2015, the US Food and Drug Administration (FDA) approved alectinib for patients with ALK-rearrangement positive non-small cell lung cancer (NSCLC) that is refractory to another ALK-targeted oral drug, crizotinib.
T-DM1 improved survival in women with HER2-positive breast cancer, even after treatment with two or more other HER2-targeted therapies including trastuzumab and lapatinib.
MRI can detect a larger tumor burden than detected by mammography alone, potentially changing treatment, according to a recently published study.
The combination of radiation therapy plus cetuximab had higher rates of acute toxicity among patients with locally advanced squamous cell carcinoma of the head and neck compared with radiation therapy plus cisplatin.
Among local treatment options for early breast cancer patients, mastectomy plus reconstruction has the highest rate of complications and is highest in cost.
The addition of denosumab to adjuvant hormonal therapy in postmenopausal breast cancer patients improves disease-free survival compared with placebo.
Cancer survivors treated with anthracycline-based chemotherapies exhibited poorer performance of certain cognitive skills.
Survival of women initially diagnosed with stage IV breast cancer has improved in the last 20 years, according to results of a retrospective cohort study.